Mitsubishi UFJ Trust & Banking’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
Mitsubishi UFJ Trust & Banking's TXG Position: Q1 2024 in Review
Mitsubishi UFJ Trust & Banking sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 147,814 shares — an estimated $8.27M sold.
Mitsubishi UFJ Trust & Banking first reported a position in TXG in Q4 2020 and held it in 13 quarters. The position peaked at $49M in Q2 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.
- Mitsubishi UFJ Trust & Banking reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
- Mitsubishi UFJ Trust & Banking sold 147,814 10x Genomics shares in Q1 2024, an estimated $8.27M.
- Mitsubishi UFJ Trust & Banking first reported a position in 10x Genomics in Q4 2020 and held it in 13 quarters.
- Mitsubishi UFJ Trust & Banking's 10x Genomics position peaked at $49M in Q2 2021.
- 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2024, filed 10 May 2024.